Lonny B. Yarmus
Advanced in Non-Small Cell Lung Cancer (NSCLC)

Dr. Lonny B. Yarmus

Pulmonary Medicine | Intensive Care Medicine
Johns Hopkins University
1800 Orleans St, 
Baltimore, MD 
Accepting New Patients
Advanced in Non-Small Cell Lung Cancer (NSCLC)
Johns Hopkins University
1800 Orleans St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lonny Yarmus is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Yarmus is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleural Effusion, Lung Nodules, Lymphofollicular Hyperplasia, Endoscopy, and Advanced Bronchoscopy. Dr. Yarmus is currently accepting new patients.

His clinical research consists of co-authoring 242 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles in the study of Non-Small Cell Lung Cancer (NSCLC).

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in MD
Hospital Affiliations
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

JOHNS HOPKINS UNIVERSITY
1800 Orleans St, Baltimore, MD 21287

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules
A Multicenter, Randomized Controlled Trial, Prospectively Evaluating the Clinical Utility of the Nodify XL2 Proteomic Classifier in Incidentally Discovered Low to Moderate Risk Lung Nodules
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural Effusions
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural Effusions
Enrollment Status: Completed
Publish Date: March 30, 2023
Intervention Type: Drug
Study Drug: LTI-01
Study Phase: Phase 2
Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique (The FROSTBITE Trial)
Safety of a Sheath Cryoprobe Bronchoscopic Transbronchial Biopsy Technique (The FROSTBITE Trial)
Enrollment Status: Completed
Publish Date: February 25, 2022
Intervention Type: Device
Study Phase: Not Applicable
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Enrollment Status: Completed
Publish Date: February 15, 2021
Intervention Type: Other
NanoSpectrometer Biomarker Discovery and Confirmation Study
NanoSpectrometer Biomarker Discovery and Confirmation Study
Enrollment Status: Terminated
Publish Date: July 22, 2020
Intervention Type: Diagnostic test
Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) With Fluoroscopy for Biopsy of Pulmonary Lesions
Multicenter, Prospective, Randomized Trial of Bronchoscopy With Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) With Fluoroscopy for Biopsy of Pulmonary Lesions
Enrollment Status: Completed
Publish Date: September 25, 2018
Intervention Type: Device
Study Phase: Not Applicable
A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound
A Multi-center Study Comparing Standard 22-gauge and 22-gauge ProCore Needles for Endobronchial Ultrasound
Enrollment Status: Completed
Publish Date: April 30, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 8 Less Clinical Trials

242 Total Publications

Identifying Clinical Research Priorities in Interventional Pulmonary: An Interventional Pulmonology Outcomes Group (IPOG) Working Group Report.
Identifying Clinical Research Priorities in Interventional Pulmonary: An Interventional Pulmonology Outcomes Group (IPOG) Working Group Report.
Journal: Annals of the American Thoracic Society
Published: June 16, 2025
Similar Doctors
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Eric D. Anderson
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Eric D. Anderson
Pulmonary Medicine | Intensive Care Medicine

Medstar Medical Group Ii LLC

3800 Reservoir Rd Nw, 
Washington, DC 
 (37.1 miles away)
202-444-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eric Anderson is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Endoscopy, and Advanced Bronchoscopy.

Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. David R. Duhamel
Intensive Care Medicine | Pulmonary Medicine
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. David R. Duhamel
Intensive Care Medicine | Pulmonary Medicine

Privia Medical Group, LLC

500 W Annandale Rd, 
Falls Church, VA 
 (42.4 miles away)
703-521-6662
Languages Spoken:
English, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

David Duhamel is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Falls Church, Virginia. Dr. Duhamel is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Gastrostomy. Dr. Duhamel is currently accepting new patients.

Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Rebecca L. Krochmal
Pulmonary Medicine | Intensive Care Medicine
Distinguished in Non-Small Cell Lung Cancer (NSCLC)
Dr. Rebecca L. Krochmal
Pulmonary Medicine | Intensive Care Medicine

Medstar Medical Group Ii LLC

1145 19th St Nw, 311 Mmg At 19th Street Nw, 
Washington, DC 
 (36.3 miles away)
202-429-2401
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Krochmal is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Krochmal is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Endoscopy, and Gastrostomy. Dr. Krochmal is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yarmus's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 7 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile